



Combined Physical Training Increases Plasma Brain-Derived Neurotropic 
Factor Levels, But Not Irisin in People Living with HIV/AIDS 
 
Joice Cristina dos Santos Trombeta*1, Roberto Carlos Vieira Junior*2, Cláudia Regina 
Cavaglieriǂ1, Ivan Luiz Padilha Bonfanteǂ1,3, Jonato Prestesǂ4, Ramires Alsamir Tibanaǂ4, Morteza 
Ghayomzadehǂ5 Vinícius Carolino Souzaǂ4, Seyedahmad Seyedalinaghiǂ5, James W. Navaltaǂ6, 
Fabrício Azevedo Voltarelliǂ7 
 
1Laboratory of Exercise Physiology, School of Physical Education, University of Campinas, 
Campinas, SP, Brazil; 2Faculty of Health Sciences, State University of Mato Grosso (UNEMAT), 
Cáceres, MT, Brazil; 3Federal Institute of Education, Science and Technology of São Paulo, 
Hortolândia campus, Hortolândia, SP, Brazil; 4Graduate Program in Physical Education, 
Faculty of Physical Education, Catholic University of Brasilia (UCB), Brasilia, Brazil; 5Iranian 
Research center for HIV/AIDS (IRCHA), Tehran University of Medical Sciences, Tehran, Iran; 
6Department of Kinesiology and Nutrition Sciences, University of Nevada, Las Vegas, USA; 
7Graduate Program in Health Sciences, Faculty of Medicine, Federal University of Mato 
Grosso (UFMT), Cuiabá, MS, Brazil. 
 
*Denotes undergraduate student author, ‡Denotes professional author  
 
ABSTRACT 
International Journal of Exercise Science 14(3): 1004-1017, 2021. This study evaluated plasma levels of 
brain-derived neurotropic factor (BDNF), irisin, and lactate in people living with HIV/AIDS who completed a 
combined physical training program. Nineteen HIV+ participants (age: 39.60 ± 10.96 years; carrier time: 7.75 ± 7.88 
years; time of ART: 6.41 ± 5.93 years) performed strength/aerobic training (combined physical training) in the same 
session for 8 weeks and levels of BDNF, irisin, and lactate were assessed. BDNF (pg/mL) was higher post-CPT (Pre: 
1258.73 ± 372.30; Post: 1504.17 ± 322.30; p < 0.001). Irisin (ng/mL) showed no change (Pre: 115.61 ± 72.41; Post: 125.87 
± 81.14; p = 0.973). There was positive correlation between irisin and lactate (mmol/L) pre (r = 0.55, p = 0.04), and 
lactate values were higher in the group with the highest value of irisin (3.65 ± 0.69 x 2.82 ± 0.59, p = 0.02). Combined 
physical training results in increased basal BDNF in people living with HIV/AIDS, this finding suggests that 
increased concentration of BDNF may be associated with decreased chances of developing cognitive disorders or 
HIV-associated dementia. Further studies involving molecular mechanisms on this subject are necessary. 
 




AIDS is an infection caused by the human immunodeficiency virus (HIV) and is characterized 
by the decreased number of circulating TCD4 + lymphocytes, depressing the immune system of 
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individuals and predisposing them to the development of opportunistic diseases that, if not 
treated, lead to death (1).  
 
Neurocognitive diseases are found in 30% to 50% of people living with HIV/AIDS (PLWHA), 
as the virus can cross the blood-brain barrier and infect the cells of glia, inducing damage and 
neural death (16). A useful biomarker, and one that perhaps will serve as a control for 
neurological changes, is brain-derived neurotrophic factor (BDNF), an important neurotrophin 
involved in the development of the parahippocampal region. Neurotrophic factors in general, 
have functions of neural regulation and differentiation as well as modulation of plasticity and 
survival of neurons and glial cells (29, 40). Several studies have shown that cognitive changes as 
well as psychiatric disorders such as depression may decrease the concentration of BDNF in 
individuals both infected and not affected by HIV (17, 23, 27). In addition, increases in BDNF 
have been shown to be negatively related to depressive symptoms and Alzheimer's disease (26), 
leading some researchers to suggest peripheral BDNF as a biomarker of these diseases (18, 31). 
Thus, it can serve as an instrument to monitor the HIV-Associated Dementia and neurocognitive 
diseases associated with HIV (HAND), for example.  
 
In addition to neurological changes, metabolic disorders are also common in PLWHA and 
undergoing Antiretroviral Therapy (ART). The use of nucleotide analogue reverse-transcriptase 
inhibitors (NRTIs) is commonly related to the onset of mitochondrial toxicity/dysfunction that 
affects several tissues, including the liver and muscles, leading to injury of the oxidative energy 
system, a fact that contributes substantially to resting hyperlactatemia and high oxidative stress 
(38). This condition indicates a possible mitochondrial dysfunction, which in this case is related 
to the inhibition of the enzyme DNA polymerase gamma by NRTIs, a phenomenon that impairs 
mitochondrial DNA replication (4). 
 
Currently, it is known that the mitochondrial dysfunction and injury of oxidative 
phosphorylation, including reduction of mitochondrial DNA and peroxisome proliferator-
activated receptor-gamma (PPARγ) expression, exert influence on the metabolic homeostasis of 
PLWHA, and irisin is one of the molecules affected. Irisin is a protein derived from proteolytic 
cleavage of the fibronectin type III domain-containing protein 5 (FNDC5) gene and is secreted 
mainly by skeletal muscle and adipose tissue in humans and animals. It is known that the 
expression of FNDC5 is increased by the PPARγ activation and by its coactivator peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 α), and may have an effect 
from physical exercise (7). However, there is little evidence in the literature about this substance 
and its relationship with PLWHA as well as its influence on resting blood lactate levels in this 
population (34). 
 
The main function of irisin is to promote energy expenditure through increased activity of 
brown adipose tissue (BAT) or the conversion of white adipose tissue (WAT) in beige, which 
have molecular characteristics close to BAT (8). This is due to the presence of a higher number 
of mitochondria stimulated by uncoupled protein 1 (UCP-1) which, when activated, divert the 
protons of the electron transport chain, decreasing the production of energy (ATP) at the 
expense of increased body temperature (thermogenesis) (7). Some studies have shown also 
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increase in irisin levels in oxidative stress conditions, inflammation and energy production 
problems (2, 5, 41), and this condition is present in this population due to the ART use (35). 
However, little is known about irisin and PLWHA, since these participants present major 
changes in the two main secretory tissues (muscle and fat) of this protein, as decreased muscle 
mass and the accumulation of adipose tissue in the abdominal area (30, 34). In addition, no study 
analyzes the irisin relation with blood lactate levels (a useful variable to analyze the metabolism 
conditions and energy production) in this population.  
 
Interestingly, the secretion of both irisin and BDNF is stimulated by muscle contraction, and 
peripheral neural stimulation via PGC1-α/FNDC5 by physical exercise enhances the expression 
and secretion of both (39). Some studies have investigated effects from exercise (39) or in specific 
populations, such as the elderly (32), Crossfit® athletes (24), endurance athletes (6), and people 
with multiple sclerosis (10), and the results are controversial depending on the type of 
intervention and/or studied population. 
 
Because the association between HIV infection and ART provokes the increased risk of 
metabolic and neurocognitive disorders, as well as the absence of studies that have evaluated 
the HIV/AIDS x irisin x BDNF x resting blood lactate interaction response to physical exercises, 
the present investigation aimed to evaluate these markers. In addition, a secondary goal was to 






A power analysis conducted a priori with G*POWER 3.1 software (Universitat Kiel, Germany). 
We based on Cho et al. (12) that aimed to analyze the combined exercise serum BDNF level in 
mid-aged women. Using the medium, standard deviation and percentage changes values of 
BDNF levels, we observed in this study an effect size of 1.27 and power of 0.97. Based on these 
data, effect size and beta power were needed in the present study at least 11 participants as a 
minimum sample. In addition, to verify the power of the present sample after the experimental 
period/study, we calculated the Post Hoc power also in the G Power 3.1. This calculation was 
based on the statistical test used in the study, the "n" obtained from 19 participants, an alpha 
significance level of 0.05, an effect size of 0.79 from the pre/post values of the means and 
standard deviation of BDNF levels (the main result of the study). As a result, we observed a beta 
power of 0.90, up from the normally stipulated 0.80, which is usually used as a minimum 
required to characterize a sample as capable of detecting a difference in a given population. 
 
As mentioned, nineteen participants infected with HIV participated in this study (11 women 
and 8 men) (age: 39.60 ± 10.96 years; Carrier time: 7.75 ± 7.88 years; Time of ART: 6.41 ± 5.93 
years); and were undergoing treatment in specialized service centers, located in the city of 
Cuiabá, Mato Grosso, Brazil. The inclusion criteria used were: minimum age of 18 years, 
sedentary or inadequately active, have no impediments that would prevent exercising, should 
be using ART, and have 85% minimum frequency of the training performed. The patients who 
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presented with cardiovascular, cancer and inflammatory diseases, TCD4 + cell counts less than 
200 cells/mm3, pregnancy, failed to obtain medical release, or did not complete all stages of 
research were excluded. No dietary intervention was performed, the participants were 
instructed to maintain food habits prior to the survey. 
 
The research was approved by the Research Ethics Committee of the Júlio Muller Universitary 
Hospital, which is linked to the Federal University of Mato Grosso (Protocol No: 673/09) and 
was based on the principles of the Declaration of Helsinki. In addition, this research was carried 
out fully in accordance to the ethical standards of the International Journal of Exercise Science 
(25). All participants provided written informed consent prior to participation. Flow of 
participants through the study is shown in the Figure 1. 
 




The experimental design is described in the figure 2 below. 
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Figure 2. Experimental design 
 
Biochemical analysis: All blood sample collections were performed in the morning (08:00-10:00) 
after a fast of 12 hours and were completed in two phases. First, for immune profile analysis, 
blood was collected at a specialized customer service (SAE), Cuiabá, Mato Grosso, Brazil. The 
variables analyzed were: quantification of viral load (method: b-DNA Kit: HIV RNA 3.0); cell 
counts for TCD4+, TCD8+, and TCD4+/TCD8 (method: flow cytometry-Facscalibur-multitest). 
On another day, the participants went to the Laboratory of Biochemistry, Molecular Biology and 
Exercise of Faculty of Physical education, Federal University of Mato Grosso, Cuiabá, Brazil for 
another blood sample collection, which was centrifuged and serum stored in a freezer at -80°C 
for further analysis of BDNF and irisin. BDNF and irisin were analyzed by ELISA (Enzyme-
Linked immunosorbent assay test) from commercial kits (R&D System Inc., Minneapolis, MN, 
USA and MyBioSource Inc., San Diego, CA, USA, respectively). The minimum detectable dose 
was 184.38 pg/mL for BDNF and 27.85 ng/mL for irisin. The coefficient of variation (irisin) 
intra- and inter-analysis was 2.9-9.5% and 5.9-7.0%, respectively, and the sensitivity was 0.0093 
pg/mL. All samples were determined in duplicate to ensure the accuracy of the results. 
 
The determination of resting blood lactate occurred after adaptation and before the beginning 
of the CPT and consisted of two blood collections, which was obtained perforation of the index 
finger (Accutrend Plus Lactimeter/BM-Lactate Tests Tapes Roche®-Germany), performed on 
two separate days. The value of the final concentration was obtained by the average of the two 
collections.  
 
Body composition: An electrical bioimpedance device (Maltron Body Composition Analyzer ®, 
Warwick) was used for the measurement of the following variables: relative body fat (%), 
relative lean mass (%), body mass index (BMI) and basal metabolic rate (BMR). The participants 
were told to not ingest alcohol, not consume food or beverages that contain stimulants, ingest a 
minimum quantity of 2 liters of water, as well as urinating up to a maximum of 30 minutes 
before the test. On the day of assessment, earrings, chains and/or rings and shoes of the 
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participants were removed. Hands and feet were cleansed, and the patients were placed supine 
on a pad where electrodes were fixed in the left hand and foot. 
 
Cardiorespiratory fitness: The 2400-meter displacement test was used to determine aerobic 
physical training prescription. This test consists of participants walking or running 2400 meters 
at the maximum speed possible. Maximal oxygen consumption (Vo2max) was estimated by the 
following formula: VO2max = distance/time x 0.2 +3.5 (13). 
 
Muscle strength: The 1 repetition maximum (RM) test was used to evaluate muscle strength of 
the participants before and after the CPT, following appropriate recommendations (9). The 
participants performed two sessions of adaptation in the bench press, leg press 45°, and biceps 
curls, in order to establish the correct execution of the movement. After the adaptation period, 
participants performed 1 RM test and re-test on two non-consecutive days (minimum of 72 h 
between testing sessions). After 5 minutes of walking on a treadmill at a light intensity (based 
on the scale of perceived exertion), the participants performed a specific warm-up of 8 
repetitions with 50% of 1 RM (according to previous loads used in the adaptation sessions), 
followed by three repetitions at 70% of 1 RM. 
 
Subsequently, repetitions were performed with progressively heavier loads, and the 1 RM was 
determined within a maximum of three attempts, using rest intervals of 3 to 5 minutes between 
retries. The intraclass correlation (ICC) coefficient was r > 0.96 for the exercises tested, 
confirming the reliability test re-test.  
 
For the prescription of resistance training, we used the 10 maximal repetitions (10 RM) test, 
which was performed on the following devices: half squat (guided bar), bench press, leg curl, 
barbell upright row, leg press 45°, triceps pulley, bending plant, dumbbell press, and biceps 
curls, following the adapted recommendations: 1) warm-up for 5 to 10 repetitions at 40 - 60% of 
estimated load, followed by a break of 1 minute; 2) execution of 3 to 5 repetitions at 60% of 
estimated load and a rest of 3 minutes; 3) load increase, trying to reach the 10 RM in up to five 
attempts, with rest between each attempt of up to five minutes. The load changes occurred as 
follows: less than 10 repetitions resulted in a reduction of up to 10%; more than two repetitions, 
in addition, resulted in increased load in the same proportion. The value registered was that 
obtained in the last successful repetition (9). The load of abdominal and plantar flexion exercises 
was analyzed through the located muscular resistance test (maximum number of executions per 
minute). 
 
Combined Physical Training (CPT): In order to complete familiarization, the participants were 
subjected to two weeks of adaptation to the gym´s equipment. The participants included in the 
survey obtained 85% minimum frequency in the training performed. Stretching exercises for the 
entire body were carried out before and after the training session. 
 
The CPT itself had a total duration of eight weeks and was carried out three times per week 
(days interspersed). The resistance training was conducted in a circuit, and the participants 
performed a single set on the following equipment: 1/2 squat (guided bar), bench press, leg curl, 
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barbell upright row, leg press 45°, triceps pulley, dumbbell press, bending plant and biceps 
curls. At the end of the circuit, there was a recovery of 90 seconds. The same sequence was then 
repeated, totaling two laps on the circuit. After resistance training was completed, the 
participants began aerobic training, which consisted of a walk lasting 30 to 40 minutes (60-70% 
of maximal heart rate monitored by a frequency meter). The periodization of CPT is described 
in Table 1. 
 
Table 1. Periodization of combined physical training 
Resistance Training     
 Weeks 1ª e 2ª 3ª e 4ª 5ª e 6ª 7ª e 8ª 
 Circuit (number of rounds) 2 2 2 2 
 Repetitions 12 a 15 10 a 12 8 a 6 4 a 6 
 Intensity (%) 60 75 85 100 
Aerobic training     
 Intensity (FCmax [%]) 60 a 70 60 a 70 60 a 70 60 a 70 
 Duration (minutes) 30 30 40 40 
 
Statistical Analysis 
The analysis of data normality was performed using the Shapiro-Wilk test, and Student's T and 
Mann-Whitney tests for parametric and nonparametric data, respectively. To check for 
correlations among BDNF, irisin and blood lactate in the moment pre-and between ∆% of change 
by training, Pearson correlation test (BDNF and irisin) and Spearman (blood lactate with BDNF 
and irisin) were performed. Taking into consideration that our hypothesis relates irisin and 
blood lactate and due to the fact that we have found a correlation between these variables at the 
moment pre-CPT, a cluster analysis was applied (K-means cluster), using the irisin level values 
of each subject. This analysis divided the "19" irisin values into two groups of clusters with the 
closest mean (higher [n = 6] and lower [n = 13] levels of irisin). The student's t-test was used to 
analyze the differences between blood lactate levels of two groups/clusters. The software used 
for all analyses was Statistica (version 6.0). The results were expressed as mean ± standard 




Prior to the beginning of the CPT, the viral load of the participants was undetectable (< 50 
copies/mL); TCD4+ lymphocytes (630 ± 173 cells/mm3) and TCD8+ (988 ± 522 cells/mm3) were 
obtained in desirable values for the safe practice of regular exercise. The table 2 shows the 
medications used by the research participants. 
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Table 2. Class of drugs used by research participants 
NRTIs: nucleoside/nucleotide analogue reverse-transcriptase inhibitors, NNTRs: non-nucleoside analogue reverse-
transcriptase inhibitors, PIs: protease inhibitors, INIs: integrase inhibitors 
 
The results of BMR and variables related to body composition and physical fitness are shown in 
table 3. No statistically significant differences were observed to BMR and body composition. 
With regard to evaluations of muscle strength and cardiorespiratory fitness, patients obtained 
statistically significant gains post-CPT for muscle strength and VO2max (Table 3). 
 
Table 3. Body composition, basal metabolic rate and physical fitness before and after combined physical training 
among people living with HIV/AIDS. 
Parameter Pre-CPT Post-CPT p-value 
Body mass (kg) 70.9 ± 18.2 70.6 ± 17.9 0.535 
BMI [kg. (m2)-1] 26.7 ± 8.0 26.5 ± 8.0 0.455 
Fat mass (%) 30.2 ± 11.3 30.5 ± 11.3 0.531 
Lean mass (%) 69.8 ± 11.3 69.5 ± 11.4 0.599 
BMR (kcal) 1438.9 ± 227.8 1437.6 ± 222.7 0.712 
Bench press (kg) 26.9 ± 13.9 31.9 ± 15.5* < 0.001 
Leg press (kg) 176.6 ± 72.6 201.9 ± 79.7* < 0.001 
Biceps curl (kg) 21.3 ± 8.1 24.4 ± 9.0* < 0.001 
VO2max (ml.kg-1.min-1) 23.7 ± 3.2 29.2 ± 5.6* < 0.001 
VO2max: maximal oxygen uptake; Results are expressed as mean ± standard deviation.  
* Statistically significant difference (p < 0.05). 
 
Participant Medicines Class of medicines 
1 Nevirapina, Estavudina, Lamivudina NNTRs, NRTIs, NRTIs 
2 Efavirenz, Tenofovir, Lamivudina NNTRs, NRTIs, NRTIs 
3 Ritonavir, Estavudina, Lamivudina, Atazanavir PIs, NRTIs, NRTIs, PIs 
4 Efavirenz, Tenofovir, Lamivudina NNTRs, NRTIs, NRTIs 
5 Efavirenz, Tenofovir, Lamivudina NNTRs, NRTIs, NRTIs 
6 Efavirenz, Tenofovir, Lamivudina NNTRs, NRTIs, NRTIs 
7 Efavirenz, Tenofovir, Lamivudina NNTRs, NRTIs, NRTIs 
8 Efavirenz, Tenofovir, Lamivudina NNTRs, NRTIs, NRTIs 
9 Nevirapina, Estavudina, Lamivudina NNTRs, NRTIs, NRTIs 
10 Nevirapina, Estavudina, Lamivudina NNTRs, NRTIs, NRTIs 
11 Efavirenz, Tenofovir, Lamivudina NNTRs, NRTIs, NRTIs 
12 Nevirapina, Estavudina, Lamivudina NNTRs, NRTIs, NRTIs 
13 Lopinovir, Ritonavir, Tenofovir, Lamividuna, Zidovudina PIs, PIs, NRTIs, NRTIs, NRTIs 
14 Efavirenz, Tenofovir, Lamivudina NNTRs, NRTIs, NRTIs 
15 Lamivudina, Zidovudina, Efavirenz NRTIs, NRTIs, NNTRs 
16 Estavudina, Lamivudina, Nevipirina NRTIs, NRTIs, NNTRs 
17 Ritonavir, Raltegravir, Darunavir, Lamivudina,Tenofovir. PIs, INIs, PIs, NRTIs, NRTIs 
18 Lopinovir, Ritonavir, Tenofovir, Lamividuna, Zidovudina PIs, PIs, NRTIs, NRTIs, NRTIs 
19 Efavirenz, Tenofovir,Lamivudina NNTRs, NRTIs, NRTIs 
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The pre-post values of irisin (A), BDNF (B) and resting blood lactate (C) levels are presented in 
figure 3. Only BDNF presented significantly higher values post-CPT (p < 0.001). In addition, there 
was a positive correlation between irisin and blood lactate (r = 0.55, p < 0.05) pre-CPT; on the 
other hand, there was no correlation with other variables, regardless of the moment analyzed. 
 
Figure 3. Serum concentrations of irisin, BDNF, and resting blood lactate Serum concentrations of irisin (A), BDNF 
(B), and resting blood lactate (C), in people living with HIV/AIDS before (pre) and after (post) combined physical 
training (CPT). Results are expressed as mean ± standard deviation. * Statistically significant difference (p <0.05). 
 
Lastly, the Cluster analysis provided evidence that the group that presented higher values of 
irisin also displays higher resting blood lactate values (Table 4). 
 
Table 4. Values of irisin and resting blood lactate after Cluster analysis. 
Variable Higher Irisin Group Smaller Irisin Group p-value 
Irisin (ng.mL-1) 203.73 ± 34.74 68.47 ± 35.34* < 0.001 
Blood lactate (mmol.L-1) 3.65 ± 0.69 2.82 ± 0.59* 0.02 




The present investigation observed changes in plasma concentrations of BDNF, irisin and 
resting blood lactate as well as analyzed the correlation between these biomarkers in PLWHA 
who completed an 8-week combined physical training program. The main results showed an 
increase in BDNF levels as well as an improvement in functional parameters (oxygen 
consumption and muscle strength) post-CPT. In addition, there was a positive correlation 
between irisin and blood lactate, where individuals with higher levels of irisin showed higher 
concentrations of resting blood lactate. 
 
Increase of BDNF: It is known that physical exercise promotes numerous health benefits, and in 
PLWHA, due to the presence or risk of neurological and metabolic changes it becomes essential, 
because regular exercise can ensure benefits to many systems including the improvement 
and/or maintenance of muscle mass, immune system, blood glucose, lipid profile, and cognitive 
function (20). In the present study, the levels of BDNF were higher post-CPT, suggesting that 
there was a modulation important, may serve as protection against the onset of Alzheimer's 
disease, and of psychiatric disorders such as depression common alterations in this population. 
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As well as, some authors suggest that concentration of BDNF it can serve as an instrument to 
monitor the HIV-Associated Dementia and neurocognitive diseases associated with HIV 
(HAND) (18, 31), we suggest that the practice of combined exercise can be part of the daily 
routine of people living with HIV. 
 
In a study performed with an animal model, increased secretion of BDNF accompanied by 
increasing neurogenesis was observed as well as decreased neuritis post-endurance training (6). 
These findings are important because PLWHA present lower levels of BDNF if compared to 
healthy individuals, strengthening our initial hypothesis. 
 
It is worth mentioning that our aim was not to evaluate the cognitive function of the participants, 
but to verify the concentrations of BDNF as well as its response to CPT. Thus, it is not possible 
to say whether there was an improvement in cognitive function of our participants, which 
would be confirmed by means of specialized tests, such as the mini-exam of the mental state 
(36). However, despite the results related to BDNF being positive, future studies are needed to 
examine the pro-BDNF and mad-BDNF isoforms since the binding of mad-BDNF to its 
membrane receptor (tyrosine kinase B (TrkB)) is needed for effective action on hippocampal 
plasticity and memory formation (21). 
 
Maintenance of hyperlactatemia: It is known that hyperlactatemia, commonly observed in 
PLWHA, is related to NRTIs, which can cause mitochondrial dysfunction (22). The patients of 
the present study displayed high resting blood lactate levels pre- and post-CPT, even with a 
significant improvement in functional parameters (muscle strength and cardiorespiratory 
fitness). Usually, the rationale for increases in resting blood lactate is based on the failure of 
oxidative phosphorylation due to mutation and the deterioration of mitochondrial DNA. The 
inhibition of the enzyme DNA polymerase g changes the replication of mitochondrial DNA, 
which is an encoder of subunits of the respiratory chain enzyme complex (3). To elucidate this 
question, further analysis of specific biomarkers (e.g. oxidative enzymes [expression and/or 
activity], and UCPs) is necessary in order to clarify mitochondrial behavior, specifically in 
PLWHA using ART, as well as the response of these biomarkers to CPT. 
 
Irisin and HIV- The Need for Further Studies: In our study, there was no change in the levels of 
irisin post-CPT, and in the only other study that determined the concentration of irisin in 
PLWHA subjected to physical training (37); on the other hand, the values of this peptide in this 
population compared to healthy participants with similar characteristics considering age, BMI 
and resting energy expenditure were higher. Interestingly, another work, which corroborated 
our findings, showed no change in the levels of irisin 48 hours after the last session of physical 
training (33). 
 
It is important to note that changes in irisin levels have been observed, in healthy participants, 
when blood sampling is performed immediately after and/or a few hours after the last training 
session (14), which did not occur in the present study. Another factor that may have contributed 
to this result may have been the time of training applied (8 weeks), which was relatively short. 
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The correlation between irisin and resting blood lactate pre-CPT was positive, as well as the 
Cluster analysis results denoting a possible relation between these metabolites. Hypothetically, 
we suggest that the increased oxidative stress, induced by ART and HIV infection itself, seems 
to be an influencer of this finding. This hypothesis is strengthened by the several results found 
in the literature (2, 5, 19, 28, 41), which shown increased oxidative stress via mitochondrial 
dysfunction and a concomitant increase in the expression of both PGC1-α and FNDC-5, causing 
the elevation of plasma irisin levels. These relationships between irisin and oxidative stress are 
suggested not only by mitochondrial dysfunctions (16, 36) but also as a protective and anti-
oxidant effect, since this peptide has been shown to be important in neutralizing free radicals 
and improving redox balance (2, 5, 28). 
 
Some studies have shown the correlation between irisin and BDNF at the molecular level. In an 
interesting study (39), it was reported that stimulation of the PGC-1α/FNDC5 pathway by 
exercise increased the expression and secretion of irisin. Taking into consideration that this same 
pathway triggers a cascade of signaling which will stimulate an unknown transcription factor 
and, mainly, the expression of BDNF (40), it is possible to suggest that physical exercise is a 
potent inducer of this neurotrophic factor, via irisin, in the healthy people. 
 
However, our results did not show a correlation between plasma levels of irisin, and BDNF, 
even with increased BDNF; and this result confirms the findings of other studies (23) conducted 
in healthy young individuals. On the contrary, a study performed with athletes found a positive 
correlation (6). Taken together, these results show that the population studied as well as the 
fitness level of the subject can be the determining factor for the discrepancy between the results 
for irisin and BDNF here reported. 
 
The present study had, at the beginning of the activities, with a total number of 25 participants, 
however, reached the final with nineteen participants and did not have a control group. The 
reasons for the discontinuity in the research were: lack of willingness of the participants to 
participate in the training sessions; family problems; motorcycle accident (figure 1). This sample 
loss characterizes the limitations of our work, although studies with this population normally 
confirm this difficulty (11, 15). In addition, it is known that the exclusion of participants in order 
to form a control group may compromise the participation of all participants involved (11, 15). 
 
Conclusion: Combined physical training program increased basal plasma concentrations of 
BDNF as well as improved muscle strength and cardiorespiratory fitness among PLWHA. There 
was a correlation between irisin and resting blood lactate levels before the CPT was initiated; in 
addition, resting blood lactate values were higher in the group with the highest value of irisin. 
There was no correlation between the plasma levels of irisin and BDNF. In relation to 
concentration BDNF in PLWHA, this finding suggests that increased concentration of BDNF 
may be associated with decreased chances of developing cognitive disorders and/or HIV-
associated dementia. Future studies can be carried out with a focus on the molecular and 
mechanistic relation between BDNF, irisin and resting blood lactate, in particular in PLWHA. 
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